PC-SOD

Beijing Tide Pharmaceutical Co., Ltd · Phase 2 active Small molecule

At a glance

Generic name	PC-SOD
Sponsor	Beijing Tide Pharmaceutical Co., Ltd
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PC-SOD CI brief — competitive landscape report
PC-SOD updates RSS · CI watch RSS
Beijing Tide Pharmaceutical Co., Ltd portfolio CI